Markets:

Overview

News

Currencies

International

Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

4.320 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 2, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

Is Recursion Pharmaceuticals a Millionaire Maker? ↗

October 16, 2025

This is the only biotech stock to attract an investment from artificial intelligence (AI) giant Nvidia.

Via The Motley Fool

Topics Artificial Intelligence Initial Public Offering

Morgan Stanley, T1 Energy, Bunge Global, Bank of America And Other Big Stocks Moving Higher On Wednesday ↗

October 15, 2025

Via Benzinga

AI Agents Usher in a New Era of Pharmaceutical Discovery: Accelerating Cures to Market

October 14, 2025

The pharmaceutical industry stands on the precipice of a revolutionary transformation, driven by the burgeoning power of artificial intelligence (AI) agents. These sophisticated, autonomous systems are...

Via TokenRing AI

Topics Artificial Intelligence Intellectual Property

Absci's AI Revolution: A New Era for Drug Discovery or a Rocky Road Ahead?

October 13, 2025

Absci (NASDAQ: ABSI), a pioneer in AI-driven drug discovery, is making significant strides with its "Integrated Drug Creation™ Platform," promising to revolutionize how new medicines are brought to...

Via MarketMinute

Topics Artificial Intelligence

2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk ↗

October 13, 2025

Absci's AI drug development platform is compelling, and its pipeline is promising...but can the company overcome execution hurdles to live up to analyst hype?

Via MarketBeat

Topics Artificial Intelligence

4 Healthcare Stocks to Buy Now ↗

October 12, 2025

As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations.

Via The Motley Fool

Topics Artificial Intelligence

Costco, AMD, Recursion Pharmaceuticals, Cipher Mining And Snowflake: Why These 5 Stocks Are On Investors' Radars Today ↗

October 08, 2025

On Wednesday, major U.S. indices closed mixed, with the Nasdaq rising 1.1% to 23,043.38 and the S&P 500 slipping nearly 0.6% to 6,753.72. The Dow Jones Industrial Average was unchanged at...

Via Benzinga

Topics Stocks

What's Going On With Recursion Pharmaceuticals Stock On Wednesday? ↗

October 08, 2025

Recursion Pharmaceuticals' stock rises on heavy trading volume, with investors eyeing its AI-designed cancer drug REC-3565 and extended cash runway.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 08, 2025

Via Benzinga

Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday ↗

October 08, 2025

Via Benzinga

Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures

October 02, 2025

A monumental leap in biomedical research has been announced with the development of a breakthrough technology capable of mapping the entire intricate network of RNA-protein interactions within human...

Via MarketMinute

Topics Artificial Intelligence Derivatives

AI Revolutionizes Professional Services: A New Era for Doctors, Lawyers, and Consultants

October 01, 2025

As of October 1, 2025, Artificial Intelligence (AI) has transcended its nascent stages, becoming an indispensable force in high-value professional tasks across medicine, law, and consulting. This...

Via MarketMinute

Topics Artificial Intelligence

Nvidia Has Invested in These 6 Companies. Should You Follow Suit? ↗

September 29, 2025

The world's most valuable company holds stakes in a number of smaller tech players.

Via The Motley Fool

Topics Artificial Intelligence

Where Will Recursion Pharmaceuticals Be in 5 Years? ↗

September 28, 2025

Could investing in this stock be an underrated way to profit from the rapidly expanding AI industry?

Via The Motley Fool

Topics Animal Testing Artificial Intelligence

The Biotech Stock That's Too Risky for Most Investors ↗

September 28, 2025

It's unclear how long it's going to be before this company has a product to sell.

Via The Motley Fool

Topics Artificial Intelligence

10 Hidden-Gem AI Stocks to Buy Right Now ↗

September 27, 2025

From AI-powered insurance bots to drug discovery platforms, these overlooked stocks offer pure-play exposure to artificial intelligence without trillion-dollar valuations.

Via The Motley Fool

Topics Artificial Intelligence

Cramer's Friday Watchlist: AI Soars as Consumer Stumbles Amidst Economic Divide

September 26, 2025

As the trading week draws to a close on Friday, September 26, 2025, Jim Cramer, the influential host of CNBC's "Mad Money," has once again offered his discerning insights into the stock market's...

Via MarketMinute

Topics Artificial Intelligence Economy Energy

Jim Cramer Says This Financial Stock Is A 'Total Spec,' Likes Dutch Bros, ↗

September 26, 2025

On CNBC's “Mad Money Lightning Round,” Jim Cramer said he likes Dutch Bros (NYSE: BROS). He recommended buying some now and then buying some of the stock in the $40s.

Via Benzinga

Prediction: 2 Stocks That Will Be Worth More Than BigBear.ai 5 Years From Now ↗

September 26, 2025

BigBear.ai is bigger than both of these AI-focused companies now. That could change.

Via The Motley Fool

Topics Artificial Intelligence

The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market

September 19, 2025

The global pharmaceutical sector stands at the precipice of a monumental transformation, driven by an unprecedented convergence of scientific breakthroughs, technological innovation, and evolving...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Lilly's AI Gambit: TuneLab Poised to Reshape Biotech Drug Discovery Landscape

September 19, 2025

Eli Lilly and Company (NYSE: LLY) has unveiled its groundbreaking TuneLab Platform, an artificial intelligence (AI) and machine learning (ML) initiative designed to democratize advanced drug discovery...

Via MarketMinute

Topics Animal Testing Artificial Intelligence Intellectual Property

Nvidia Has $4.3 Billion Invested in These 6 Artificial Intelligence (AI) Stocks. Here's the Best of the Bunch. ↗

September 15, 2025

Most of Nvidia's AI bets are riding on one stock.

Via The Motley Fool

Topics Artificial Intelligence

What Analysts Are Saying About Recursion Pharmaceuticals Stock ↗

September 11, 2025

Via Benzinga

When You Buy Nvidia Stock, You Get a Bonus: An Artificial Intelligence (AI) ETF of Sorts ↗

September 03, 2025

Nvidia's six-stock portfolio of publicly traded AI stocks was worth $4.3 billion at the end of the second quarter, and the company also owns stakes in many privately held AI start-ups.

Via The Motley Fool

Topics Artificial Intelligence ETFs Regulatory Compliance

3 AI Stocks Disrupting Trillion-Dollar Industries ↗

September 02, 2025

These three companies are using artificial intelligence (AI) to transform defense, pharmaceuticals, and banking.

Via The Motley Fool

Topics Artificial Intelligence Economy

If You'd Invested $1,000 in Recursion Pharmaceuticals 4 Years Ago, Here's How Much You'd Have Today ↗

August 29, 2025

This AI company isn't yet living up to the hype.

Via The Motley Fool

Topics Artificial Intelligence

Powering Progress: AI's Insatiable Energy Appetite and Biotech's Dual Dawn

August 27, 2025

The global economy in 2025 is navigating a landscape profoundly reshaped by the escalating demands of Artificial Intelligence (AI) and transformative shifts in healthcare. While the burgeoning energy...

Via MarketMinute

Topics Artificial Intelligence Economy Emissions

Recursion to Participate in Upcoming Investor Conferences

August 27, 2025

From Recursion Pharmaceuticals

Via GlobeNewswire

1 Reason to Buy This Beaten-Down Artificial Intelligence (AI) Stock, and 2 Reasons to Sell ↗

August 25, 2025

There might be better artificial intelligence (AI) stocks out there to buy.

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property

The Next Big Thing: 2 AI-Powered Healthcare Stocks Ready to Explode ↗

August 23, 2025

The artificial intelligence revolution is leaving no opportunity unaddressed.

Via The Motley Fool

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.